Ligand Pharmaceuticals Investor Relations Material
Latest events
Q1 2025
Ligand Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ligand Pharmaceuticals Incorporated
Access all reports
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that focuses on developing and licensing innovative technologies and drug discovery platforms to pharmaceutical companies. Ligand’s business model centers around partnerships, where it provides proprietary drug development technologies such as its OmniAb antibody discovery platform and Captisol drug formulation technology. These technologies are used to support the development of therapies across a wide range of therapeutic areas, including oncology, infectious diseases, and autoimmune disorders. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
LGND
Country
🇺🇸 United States